¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ (¿Â¶óÀÎ&¿ÀÇÁ¶óÀÎ º´Çà) LMCE 2020 & KSLM 61st Annual Meeting : 2020-09-24

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ (¿Â¶óÀÎ&¿ÀÇÁ¶óÀÎ º´Çà) LMCE 2020 & KSLM 61st Annual Meeting : 2020-09-24
±³À°ÀÏÀÚ : 2020-09-24
±³À°Àå¼Ò : ¿Â¶óÀÎ & ¿ÀÇÁ¶óÀÎ µ¿½Ã °³ÃÖ ¿¬¼ö±³À° (¿ÀÇÁ¶óÀÎ: ¼ÛµµÄÁº¥½Ã¾Æ Room A~F )  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ&¿ÀÇÁ¶óÀÎ º´Çà) LMCE 2020 & KSLM 61st Annual Meeting      
ÁÖÃÖ±â°ü : ´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ
´ã´çÀÚ : ±èÈñ¼ø 
¿¬¶ôó : 02-795-9914  
À̸ÞÀÏ : kscp3@kams.or.kr      
±³À°Á¾·ù : Áø´Ü°Ë»çÀÇÇаú      
Âü¼®¿¹»óÀοø : 500¸í
Èñ¸ÁÆòÁ¡ : 6Á¡ (ÀÏ¹Ý 4Á¡ / Çʼö 2Á¡)  
Áö¿ª : ÀÎõ±¤¿ª½Ã
±³À°½Ã°£ : 16 ½Ã°£ 0ºÐ  
¼¼ºÎ¼ö°­·á : 100,000¿ø      
ºñ°í Á¤È¸¿ø-10¸¸¿ø/ÁØȸ¿ø.º´¸®»ç-8¸¸¿ø/ºñȸ¿ø-25¸¸¿ø      
       
±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09¿ù 24ÀÏ Room C (Room 116-117) / ¿Â¶óÀΠ08:00~08:20 SY5C: Current status of korean association of external quality assessment service and proficiency testing  Kyunghoon Lee(Seoul National University College of Medicine Korea) 
±³À°½Ã°£ 09¿ù 24ÀÏ Room C (Room 116-117) / ¿Â¶óÀΠ08:20~08:40 SY5C: Result of 12 years implementing EQA for medical laboratories in Vietnam  Truong Quan Thuy(Center for Standardization and Quality control in Medical Lab of Ho Chi Minh City Vietnam) 
±³À°½Ã°£ 09¿ù 24ÀÏ Room C (Room 116-117) / ¿Â¶óÀΠ08:40~09:00 SY5C: External quality assurance system in medical laboratories: Myanmar experience  Wah Wah Aung(Advanced Molecular Research Centre Myanmar) 
±³À°½Ã°£ 09¿ù 24ÀÏ Room C (Room 116-117) / ¿Â¶óÀΠ09:00~09:20 SY5C: External quality assurance system in mongolia  OYUNDELGER Munkhtuvshin Ertsuud(Mongolian Association of the Laboratory Medicine Mongolia) 
±³À°½Ã°£ 09¿ù 24ÀÏ Room C (Room 116-117) / ¿Â¶óÀΠ09:40~10:00 SY5C: Risk assessment for external quality assurance program --> Risk assessment for external quality assurance choices in clinical laboratories  Yi-Ching Lin(College of Medicine Kaohsiung Medical University Taiwan) 
±³À°½Ã°£ 09¿ù 24ÀÏ Room C (Room 116-117) / ¿Â¶óÀΠ10:00~10:20 SY5C: External quality assurance system in clinical chemistry: Present status in India  Praveen Sharma(All India Institute of Medical Sciences India) 
±³À°½Ã°£ 09¿ù 24ÀÏ Room C (Room 116-117) / ¿Â¶óÀΠ10:20~10:40 SY5C: Current status of external quality assurance system in japan  Katsuo Kubono(Niigata University of Health and Welfare Japan) 
±³À°½Ã°£ 09¿ù 24ÀÏ Room C (Room 116-117) / ¿Â¶óÀΠ10:40~11:00 SY5C: Implementation of national external quality assurance scheme (EQAS) to achieve harmonization of laboratory result: indonesia¡¯s experience  Agus Susanto Kosasih(Dharmais Hospital National Cancer Center Indonesia) 
±³À°½Ã°£ 09¿ù 24ÀÏ Room A (Premier A+B) 08:30~09:00 SY6A: Vitamin B12 and folate deficiency and its laboratory investigation; Comparison of diagnostic accuracy of active B12 and total vitamin B12.  Barnali Das(Kokilaben Dhirubhai Ambani Hospital & Medical Research Institute India) 
±³À°½Ã°£ 09¿ù 24ÀÏ Room A (Premier A+B) 09:00~09:30 SY6A: Laboratory assessment in the diagnosis and management of parathyroid disease  Soo Young Moon(Pusan National University School of Medicine Korea) 
±³À°½Ã°£ 09¿ù 24ÀÏ Room A (Premier A+B) 09:30~10:00 SY6A: Urine free cortisol in the diagnosis of cushing¡¯s syndrome  Jooyoung Cho(Yonsei University Wonju College of Medicine Korea) 
±³À°½Ã°£ 09¿ù 24ÀÏ Room B (Premier C) 08:30~09:00 SY6B: PHEIC (Public Health Emergency of International Concern)  Jeong Su Park(Seoul National University College of Medicine Korea) 
±³À°½Ã°£ 09¿ù 24ÀÏ Room B (Premier C) 09:00~09:30 SY6B: SARS-CoV-2 & COVID-19 in Korea  Heungsup Sung(University of Ulsan College of Medicine Korea) 
±³À°½Ã°£ 09¿ù 24ÀÏ Room B (Premier C) 09:30~10:00 SY6B: EUA (Emergency Use Authorization) in Korea¡¯s Coronavirus outbreak  Hyukmin Lee(Yonsei University College of Medicine Korea) 
±³À°½Ã°£ 09¿ù 24ÀÏ Room A (Premier A+B)/ ¿Â¶óÀΠ11:00~12:00 PL02: Clinical lab 2.0: How the laboratory can support value based care, optimize patient outcomes, and reduce total costs of care  David G. Grenache(American Association for Clinical ChemistryTriCore Reference Laboratories USA) 
±³À°½Ã°£ 09¿ù 24ÀÏ Room A (Premier A+B) 13:00~13:40 KS01: Genomics, Metabolomics and the diagnosis of rare diseases  Ching-Wan Lam(The University of Hong Kong Hong Kong) 
±³À°½Ã°£ 09¿ù 24ÀÏ Room A (Premier A+B)/ ¿Â¶óÀΠ13:40~14:10 SY7A: What to Do When You Don¡¯t Have Tissue: Cell-Free Tumor DNA  Christina M. Lockwood(University of Washington USA) 
±³À°½Ã°£ 09¿ù 24ÀÏ Room A (Premier A+B)/ ¿Â¶óÀΠ14:10~14:40 SY7A: What to Do When DNA Fails: RNA-Based Next-Generation Sequencing  Seung-Tae Lee(Yonsei University College of Medicine Korea) 
±³À°½Ã°£ 09¿ù 24ÀÏ Room A (Premier A+B)/ ¿Â¶óÀΠ14:40~15:10 SY7A: What to Do When You Don¡¯t Have Enough: Droplet Digital PCR  Vera Ashley Paulson(University of Washington USA) 
±³À°½Ã°£ 09¿ù 24ÀÏ Room B (Premier C) 13:40~14:10 SY7B: Technical innovation and laboratory medicine and infection control  Ki Ho Hong(Seoul Medical Center Korea) 
±³À°½Ã°£ 09¿ù 24ÀÏ Room B (Premier C) 14:10~14:40 SY7B: New diagnostics test for HAI in primary-care hospitals  Hyukmin Lee(Yonsei University College of Medicine Korea) 
±³À°½Ã°£ 09¿ù 24ÀÏ Room B (Premier C) 14:40~15:10 SY7B: New approach to diagnosis of multidrug-resistant pathogens  YoungJin Kim(Kyung Hee University School of Medicine Korea) 
±³À°½Ã°£ 09¿ù 24ÀÏ Room B (Premier C) 15:10~15:40 SY7B: The current status of C. difficile infection diagnosis; meaning of laboratory diagnosis  Bo-Mun Shin(Inje University College of Medicine Korea) 
±³À°½Ã°£ 09¿ù 24ÀÏ Room C (Room 116-117) 13:40~14:00 SY7C: Major subjects of IVD regulations and designation for the institute of clinical performance test  Seung Yong Lee(Ministry of Food and Drug Safety Korea) 
±³À°½Ã°£ 09¿ù 24ÀÏ Room C (Room 116-117) 14:00~14:20 SY7C: Process of Emergency Use Authorization (EUA) in Korea and other countries  Kyoung Ho Roh(National Health Insurance Service Ilsan Hospital Korea) 
±³À°½Ã°£ 09¿ù 24ÀÏ Room C (Room 116-117) 14:20~14:40 SY7C: Experience of COVID-19 IVD approval for each country  Jinkoo Kang(Seegene co. Korea) 
±³À°½Ã°£ 09¿ù 24ÀÏ Room C (Room 116-117) 14:40~15:10 SY7C: Regulation and process of clinical performance test for IVD approval  Young-Wook Ahn(National Institute of Food and Drug Safety Evaluation Korea) 
±³À°½Ã°£ 09¿ù 24ÀÏ Room A (Premier A+B) / ¿Â¶óÀΠ16:00~16:25 SY8A: Laboratory response for COVID019 in Korea: Lessons from the past  Gab Jung Kim(°¨¿°º´Áø´Ü°ü¸®°ú Korea) 
±³À°½Ã°£ 09¿ù 24ÀÏ Room A (Premier A+B) / ¿Â¶óÀΠ16:25~16:50 SY8A: Laboratory response for COVID019 in Korea: For future 2nd wave  Hyukmin Lee(Yonsei University College of Medicine Korea) 
±³À°½Ã°£ 09¿ù 24ÀÏ Room A (Premier A+B) / ¿Â¶óÀΠ16:50~17:10 SY8A: Genome-wide characterization of point mutations in SARS-CoV-2 Genome  Jun-Sub Kim(¹ÙÀÌ·¯½ººÐ¼®°ú Korea) 
±³À°½Ã°£ 09¿ù 24ÀÏ Room A (Premier A+B) / ¿Â¶óÀΠ17:10~17:30 SY8A: Problem solving in SARS-CoV-2 molecular testing  Heungsup Sung(University of Ulsan College of Medicine Korea) 
±³À°½Ã°£ 09¿ù 24ÀÏ Room B (Premier C) 16:00~16:30 SY8B: Next-generation sequencing and next-generation flowcytometry in diagnostics of plasma cell disorder: Is it more useful and informative for treatment in real-world clinical settings?  Hyun-Young Kim(Sungkyunkwan University School of Medicine Korea) 
±³À°½Ã°£ 09¿ù 24ÀÏ Room B (Premier C) 16:30~17:00 SY8B: Diagnostics of myelodysplastic syndrome: Can the genetics open the door to perfect diagnosis?  Young-Uk Cho(University of Ulsan College of Medicine Korea) 
±³À°½Ã°£ 09¿ù 24ÀÏ Room B (Premier C) 17:00~17:30 SY8B: Germline variant screening in myeloid neoplasms: Should it be routinely tested in all patients?  Borahm Kim(Korea University College of Medicine Korea) 
±³À°½Ã°£ 09¿ù 24ÀÏ Room A (Premier A+B) / ¿Â¶óÀΠ17:30~18:10 KS02: PML-RARA: Lessons from the chimera and the curable leukemia  Scott C. Kogan(University of California USA) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ (¿Â¶óÀÎ&¿ÀÇÁ¶óÀÎ º´Çà) LMCE 2020 & KSLM 61st Annual Meeting : 2020-09-24""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û °æ±âµµÀÇ»çȸ Çϳ²½ÃÀÇ»çȸ¿¬¼ö°­Á : 2020-09-24
´ÙÀ½±Û ´ëÇÑÀ̺ñÀÎÈÄ°úÇÐȸ ´ë±¸ ¡¤ °æºÏ ÁöºÎȸ Á¦1Â÷ ÇмúÁý´ãȸ : 2020-09-24
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20694 ´ëÀü Á¦8ȸ ³»ºÐºñ ÃÊÀ½ÆÄ ¹× ±â´É°Ë»ç ¿¬¼ö°­Á : 2024-06-29 0 28 2024-05-11
20693 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 4Â÷ : 2024-06-29 0 26 2024-05-11
20692 ¼­¿ï Á¦24ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ : 2024-06-28 0 31 2024-05-11
20691 °æ±â Á¤½Å°Ç°­ÀÇÇаú ÀÓ»ó¿¡¼­ À¯¿ëÇÑ Ä¡·á¹ý : 2024-06-26 0 32 2024-05-11
20690 ¼­¿ï (¿Â¶óÀÎ)2024 ÇѾç´ëÇб³º´¿ø È£Èí±â¾Ë·¹¸£±â ¿¬¼ö°­Á : 2024-06-22 0 28 2024-05-11
20689 ºÎ»ê °í½Å´ëÇб³º¹À½º´¿ø Á¦20ȸ °©»ó¼±¿¬¼öȸ : 2024-06-22 0 20 2024-05-11
20688 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 3Â÷ : 2024-06-22 0 7 2024-05-11
20687 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (2ÀÏÂ÷) : 2024-06-22 0 8 2024-05-11
20686 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 2 : 2024-06-21 0 16 2024-05-11
20685 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (1ÀÏÂ÷) : 2024-06-21 0 11 2024-05-11
20684 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 1 : 2024-06-20 0 6 2024-05-11
20683 ¼­¿ï ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ (¿Â¶óÀÎ) ¼­¿ï°æÀÎÁöȸ 277Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-18 0 20 2024-05-11
20682 ¼­¿ï 2024 °­µ¿±¸ÀÇ»çȸ Á¦3Â÷ ¿¬¼ö±³À°(¿°Áõ¼º ÀåÁúȯ,ºñ¸¸ ¾à¹° Ä¡·á ) : 2024-06-17 0 11 2024-05-11
20681 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ Á¦29Â÷ ´ç´¢º´ ¿¬¼ö°­Á : 2024-06-16 0 19 2024-05-11
20680 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 2Â÷ : 2024-06-15 0 13 2024-05-11
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷